-
1دورية أكاديمية
المؤلفون: Tsai, Katy K, Zarzoso, Inés, Daud, Adil I
المصدر: Human Vaccines & Immunotherapeutics. 10(11)
مصطلحات موضوعية: Cancer, Immunization, Climate-Related Exposures and Conditions, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, B7-H1 Antigen, CTLA-4 Antigen, Humans, Immunotherapy, Lymphocyte Activation, Melanoma, Nivolumab, Programmed Cell Death 1 Receptor, T-Lymphocytes, BMS-936559, PD-1, PD-L1, PD-L2, immunotherapy, MPDL3280A, melanoma, nivolumab, pembrolizumab, AE, adverse event, APC, antigen presenting cell, ASCO, American Society of Clinical Oncology, CTLA-4, cytotoxic T-lymphocyte-associated protein 4, FDA, Food and Drug Administration, gp100, glycoprotein 100 vaccine, Ig, immunoglobulin, ITIM, immunoreceptor tyrosine-based inhibitory motif, ITSM, immunoreceptor tyrosine-based switch motif, MAPK, mitogen-activated protein kinase, MHC, major histocompatibility complex, NK, natural killer, ORR, objective response rate, OS, overall survival, PD, progressive disease, programmed cell death 1, programmed cell death ligand 1, PFS, progression free survival, TCR, T cell receptor, TIL, tumor infiltrating lymphocyte, AE, adverse event, APC, antigen presenting cell, ASCO, American Society of Clinical Oncology, CTLA-4, cytotoxic T-lymphocyte-associated protein 4, FDA, Food and Drug Administration, ITIM, immunoreceptor tyrosine-based inhibitory motif, ITSM, immunoreceptor tyrosine-based switch motif, Ig, immunoglobulin, MAPK, mitogen-activated protein kinase, MHC, major histocompatibility complex, NK, natural killer, ORR, objective response rate, OS, overall survival, PD, progressive disease, PD-1, programmed cell death 1, PD-L1, programmed cell death ligand 1, PFS, progression free survival, TCR, T cell receptor, TIL, tumor infiltrating lymphocyte, gp100, glycoprotein 100 vaccine, Immunology, Medical Microbiology, Pharmacology and Pharmaceutical Sciences, Virology
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/49q8w2djTest
-
2
المؤلفون: Katarzyna Guzik, Przemyslaw Grudnik, Bartosz J. Zieba, Krzysztof M. Zak, Grzegorz Dubin, Bogdan Musielak, Alexander Dömling, Tad A. Holak
المساهمون: Drug Design, Medicinal Chemistry and Bioanalysis (MCB)
المصدر: Oncotarget
Oncotarget, 7(21), 30323-30335. Impact Journals LLCمصطلحات موضوعية: Models, Molecular, 0301 basic medicine, Magnetic Resonance Spectroscopy, CLINICAL ACTIVITY, Programmed Cell Death 1 Receptor, drug protein binding, Plasma protein binding, ANTI-PD-L1 ANTIBODY, Pharmacology, Crystallography, X-Ray, drug research, THERAPY, B7-H1 Antigen, PROTEIN-PROTEIN INTERACTIONS, 0302 clinical medicine, Checkpoint inhibitor, binding affinity, conformational transition, Molecular Structure, Drug discovery, Chemistry, CHECKPOINT BLOCKADE, article, Ligand (biochemistry), Small molecule, unclassified drug, bms 8, Oncology, protein stability, MPDL3280A, 030220 oncology & carcinogenesis, protein protein interaction, CANCER-IMMUNOTHERAPY, immunotherapy, Immunotherapy, drug potency, Protein Binding, Signal Transduction, Research Paper, crystal structure, bms 37, medicine.drug_class, small molecule, Monoclonal antibody, Protein–protein interaction, Small Molecule Libraries, 03 medical and health sciences, Protein Domains, complex formation, inhibition kinetics, medicine, Humans, controlled study, human, nuclear magnetic resonance spectroscopy, STABILITY, drug targeting, bms 202, programmed death 1 receptor, molecular dynamics, NMR, programmed death 1 ligand 1, drug structure, checkpoint inhibitor, 030104 developmental biology, Targeted drug delivery, protein inhibitor, Biophysics, bms 242, drug synthesis, X-ray structure, INHIBITORS
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4077c489c1a3e54f918f43d3ca7d076cTest
https://hdl.handle.net/11370/66b38ebe-19cb-4ca3-bd38-d873a99853beTest -
3
المؤلفون: Jedd D. Wolchok, David B. Page, Jarushka Naidoo
المصدر: British Journal of Cancer
مصطلحات موضوعية: Cancer Research, anti-PD-L1, medicine.medical_treatment, Ipilimumab, Immune system, tremelimumab, Antigen, Neoplasms, medicine, Humans, Antibody-dependent cell-mediated cytotoxicity, nivolumab, anti-CTLA4, business.industry, Immunotherapy, BMS-936559, Immune checkpoint, Oncology, MPDL3280A, Immunology, anti-PD-1, Minireview, Nivolumab, business, Tremelimumab, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23d6166bdfa37af6284efa3ef85ad2b5Test
http://europepmc.org/articles/PMC4264429Test -
4
المؤلفون: Ali, H. Raza, Dariush, Aliakbar, Provenzano, Elena, Bardwell, Helen, Abraham, Jean E., Iddawela, Mahesh, Vallier, Anne-Laure, Hiller, Louise, Dunn, Janet. A., Bowden, Sarah J., Hickish, Tamas, McAdam, Karen, Houston, Stephen, Irwin, Mike J., Pharoah, Paul D. P., Brenton, James D., Walton, Nicholas A., Earl, Helena M., Caldas, Carlos
المساهمون: Ali, Raza [0000-0001-7587-0906], Abraham, Jean [0000-0003-0688-4807], Irwin, Mike [0000-0002-2191-9038], Pharoah, Paul [0000-0001-8494-732X], Brenton, James [0000-0002-5738-6683], Walton, Nicholas [0000-0003-3983-8778], Earl, Helena [0000-0003-1549-8094], Caldas, Carlos [0000-0003-3547-1489], Apollo - University of Cambridge Repository
المصدر: Breast Cancer Research : BCR
مصطلحات موضوعية: Adult, PROGNOSIS, PROTEIN EXPRESSION, AUTOMATED-ANALYSIS, Receptor, ErbB-2, Biopsy, Immunology, Breast Neoplasms, Treatment resistance, SYSTEMS PATHOLOGY, RC0254, Breast cancer, Antineoplastic Combined Chemotherapy Protocols, Biomarkers, Tumor, Humans, TUMOR-INFILTRATING LYMPHOCYTES, Oncology & Carcinogenesis, Lymphocytes, ANTHRACYCLINE CHEMOTHERAPY, Aged, Epirubicin, Medicine(all), Science & Technology, ASSOCIATION, Middle Aged, Computational pathology, Neoadjuvant Therapy, QR, Oncology, MPDL3280A, Chemotherapy, Adjuvant, NEO-TANGO, TRIAL, Female, Taxoids, Neoadjuvant, Life Sciences & Biomedicine, 1112 Oncology And Carcinogenesis, Research Article
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8fcf24df1dcbb7bf1c385b8feb48f5faTest
http://wrap.warwick.ac.uk/85329/1/WRAP_art%3A10.1186%2Fs13058-016-0682-8.pdfTest